Ruth Beadle, head, global supply chain, Sanofi, explains how the company balances daily operations with long-term ...

In the first part of his Pharma Commerce video interview, Kevin Dondarski, Deloitte’s life sciences R&D strategy leader, ...

A qualitative study aimed to strengthen systematic repurposing efforts within rare disease nonprofit organizations, while also providing a framework for data-driven drug repurposing.

Andrew Witty resigns due to personal reasons, as Stephen Hemsley, chairman and former chief executive, will assume the ...

Similar to tariffs in which Trump felt that the United States was not treated fairly when it came to be taxed on certain ...

In the final part of his Pharma Commerce video interview, Michael Rowe, Two Labs’ senior director of DSCSA/serialization ...

In the third part of his Pharma Commerce video interview, Michael Rowe, Two Labs’ senior director of DSCSA/serialization ...

The financial decision is due to customer demand stemming from the reshoring of drug supply services.

However, in order to fully unlock these massive opportunities, life science companies must embrace a new way of operating and ...

Will Pih, co-founder, Two Labs, explains how specialty pharmacies and manufacturers are adapting to financial pressures in ...

Tiara Green, president, Accessia Health, explains how empowering trusted local leaders and involving communities early are ...

In the second part of his Pharma Commerce video interview, Michael Rowe, Two Labs’ senior director of DSCSA/serialization ...